PreScission Protease for Precision Tag Removal

Affinity tags simplify recombinant expression, but they can interfere with oligomerization, binding assays, localization studies, or enzymatic activity. PreScission Protease (PSP) offers a controlled solution: it is a recombinant HRV 3C protease fused to glutathione S-transferase (GST), produced in Escherichia coli, and designed to recognize the sequence Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro. Cleavage occurs between the glutamine and glycine residues, making the enzyme useful when a defined junction has been engineered between a purification tag and the target protein.

APExBIO supplies PSP as a sterile, colorless liquid for workflows that require precise fusion protein tag cleavage rather than broad-spectrum proteolysis. Its low-temperature operating profile is particularly useful for unstable protein domains, multimeric complexes, and samples destined for structural or interaction assays.

Setup and principle: designing a clean cleavage experiment

PSP is best understood as a site-specific protein purification enzyme. The target construct must contain an accessible prescission protease cleavage site, usually positioned between an affinity tag and the recombinant protein. Because the recognition sequence is longer than a simple dipeptide, the design can provide useful selectivity; however, sequence presence alone does not guarantee efficient processing. The junction must also be exposed in the folded or partially folded substrate.

For a conventional workflow, the fusion protein is first captured by an affinity resin, washed to remove host contaminants, and then exposed to PSP either on the resin or after elution. Cleavage at the Gln-Gly bond can release a target with a near-native N terminus, depending on the exact construct architecture. Researchers should confirm the first residues of the released product by sequence design, intact-mass analysis, or N-terminal sequencing when the terminus is functionally important.

Low temperature is an important part of the operating strategy. The product information recommends activity at approximately 4°C and storage at -80°C; aliquots may be stored at -20°C for up to six months according to the PreScission Protease (PSP) product information. These conditions are handling guidance, not a substitute for a substrate-specific optimization experiment. Small aliquots help avoid repeated freeze-thaw exposure, which can reduce reproducibility even when the cleavage site is correctly designed.

Key Innovation from the Reference Study

The reference study identified a molecular and genetic interaction between Drosophila Keap1, or dKeap1, and the B-type lamin lamin Dm0. In the reported experiments, ectopic dKeap1 expression was associated with redistribution of lamin into the intranuclear compartment, changes in nuclear-lamina morphology, and spreading of the heterochromatin marker H3K9me2 into euchromatic regions. Reducing dKeap1 partially rescued lethality associated with lamin overexpression, supporting a functional interaction during development. The findings are described in the reference study on dKeap1 and lamin Dm0.

The study did not establish PSP as part of its experimental method, and its in vivo Drosophila results should not be presented as direct evidence that PSP cleaves dKeap1 or lamin Dm0. Instead, the work suggests a practical assay-development opportunity: produce recombinant dKeap1, lamin Dm0, or selected interaction domains with removable affinity tags, then compare tagged and cleaved proteins in biochemical assays. A tag-free preparation can help determine whether an observed interaction reflects the protein surface of interest or an artifact of the fusion partner.

For example, a purified-protein study could combine pull-down or co-elution measurements with orthogonal readouts that reflect the paper’s biological themes, such as protein association, nuclear-architecture localization, or H3K9me2-related chromatin phenotypes in an appropriate cellular model. The important assay choice is not simply whether cleavage occurs; it is whether removal of the tag changes binding, solubility, oligomerization, or downstream activity.

Why this cross-domain matters, maturity, and limitations

The bridge from affinity-tag processing to nuclear-architecture biology is experimentally useful but remains an enabling strategy, not a conclusion of the reference study. PSP can improve the biochemical quality of recombinant inputs used to test hypotheses raised by the dKeap1–lamin findings. It cannot reproduce the developmental genetics, chromatin context, or nuclear organization measured in intact Drosophila tissues. A robust project should therefore use cleavage as one control within a larger design: tagged protein, cleaved protein, cleavage-reaction control, and ideally a construct in which the recognition site is altered without changing the rest of the protein.

Step-by-step workflow and protocol enhancements

1. Confirm construct architecture before expression

Inspect the sequence from the affinity tag through the PSP recognition site and into the target. Confirm the exact Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro motif, verify that the cleavage junction is in frame, and check whether residues retained after cleavage are acceptable for the intended assay. A flexible linker can improve access, but it should be tested because an overly long or compositionally unusual linker may affect folding or interaction measurements.

2. Prepare a clean, compatible substrate

After affinity capture, remove insoluble material and exchange the sample into a cleavage-compatible buffer when the expression or wash buffer contains components that inhibit the enzyme or destabilize the target. Maintain the protein at a concentration that avoids visible precipitation. For sensitive dKeap1 or lamin fragments, collect a pre-cleavage sample so that any later change in oligomerization or binding can be attributed to tag removal rather than storage or buffer exchange.

3. Run a small pilot before scaling

The following starting matrix is a workflow recommendation rather than a guaranteed product specification. It is designed to reveal whether the limiting factor is enzyme amount, reaction time, temperature, or substrate accessibility.

Protocol Parameters

• Substrate setup: Prepare a 100 µL pilot containing 0.5–1.0 mg/mL fusion protein in a cleavage buffer near neutral pH; include a no-enzyme control at the same volume and temperature.
• Temperature and enzyme screen: Incubate at 4°C with preliminary PSP-to-substrate mass ratios of 1:50 and 1:100, sampling after 2 hours and 16 hours to distinguish rapid from incomplete cleavage.
• Buffer starting point: Test 20 mM Tris-HCl, 150 mM NaCl, 1 mM DTT, and 1 mM EDTA at pH 7.5–8.0 and 4°C; validate each additive against the target protein and downstream assay.
• Reaction monitoring: Remove 10 µL aliquots at 0, 2, and 16 hours, quench or place them on ice, and compare intact fusion protein, released target, and residual tag by SDS-PAGE or an equivalent analytical method.
• Scale-up decision: Increase the reaction volume from 100 µL to 1 mL only after the pilot shows a reproducible cleavage pattern without visible precipitation or loss of target material.

When the target remains bound to an affinity resin, gentle mixing can improve access to the cleavage site without exposing the protein to an additional elution step. When cleavage is performed after elution, monitor the sample by size-exclusion chromatography or analytical ultracentrifugation if oligomerization is central to the experiment. The best condition is the one that produces the desired molecular form, not necessarily the fastest disappearance of the tagged band.

Advanced applications and comparative advantages

PSP is differentiated from nonspecific proteases by its reliance on a defined HRV 3C recognition sequence. That selectivity makes it attractive for GST fusion protein cleavage, removal of solubility tags, and preparation of proteins for binding or structural assays where unwanted proteolysis would complicate interpretation. Compared with workflows that use harsh chemical cleavage or broad-spectrum enzymes, HRV 3C processing can be gentler on multidomain proteins, although every substrate still requires validation.

The GST fusion format of PSP can also support a practical polishing step. If the released target does not bind glutathione resin, the GST-containing protease and cleaved tag may be removed by a second glutathione-affinity capture, provided that resin compatibility and target flow-through behavior have been confirmed. This approach is especially useful when residual protease could interfere with a sensitive interaction assay.

For nuclear-architecture projects, a useful comparison is to express dKeap1 or lamin Dm0 fragments with the tag retained, then repeat the assay after cleavage. A difference in co-purification, sedimentation, or microscopy behavior becomes more informative when the experiment includes an enzyme-only control and a mock-cleaved control. The previously published HRV 3C precision tag-cleavage guide complements this article by focusing on low-temperature processing and tag-removal logic, whereas the present workflow extends that principle to hypothesis-driven chromatin and lamin assays.

Troubleshooting and optimization tips

No detectable cleavage

First, recheck the recognition sequence and reading frame. A single substitution near the Gln-Gly bond, an inaccessible site buried in a folded domain, or aggregation of the substrate can produce an apparent enzyme failure. Run the 1:50 versus 1:100 enzyme screen, compare 2-hour and 16-hour samples, and keep the reaction at 4°C during the initial test. If the protein is immobilized, compare on-resin cleavage with cleavage after elution because resin proximity can either expose or obstruct the junction.

Partial cleavage or multiple product bands

Partial processing may reflect limited accessibility rather than insufficient enzyme. Test a flexible linker, reduce the protein concentration, or extend the incubation from 2 hours to 16 hours at 4°C. Multiple bands should be evaluated against the no-enzyme control and the time-zero sample. If new bands appear only with enzyme, consider target instability or secondary proteolysis and confirm the identity of the intended product by mass or immunodetection.

Loss of solubility or activity

Low-temperature protease activity can preserve labile proteins, but a cold reaction does not prevent aggregation caused by concentration, salt, or domain exposure after tag removal. Compare 0.5 mg/mL and 1.0 mg/mL substrate conditions, keep samples gently mixed, and analyze soluble and insoluble fractions separately. If the target is active only in a complex, test cleavage before reconstitution and after reconstitution rather than assuming that the tag has no structural role.

Residual PSP or tag contaminates the product

Use a second affinity step only after confirming the target’s binding behavior. Because PSP contains a GST fusion partner, glutathione-based removal may be feasible, but the target could also interact nonspecifically with the resin. Include a resin-only control and compare the final preparation by SDS-PAGE, activity testing, and, when relevant, a binding assay. Avoid repeated freeze-thaw cycles; prepare working aliquots and return unused material to the recommended storage condition.

Future outlook

The dKeap1–lamin Dm0 study strengthens the case for separating protein-production artifacts from genuine molecular interactions in chromatin and nuclear-architecture research. PSP can contribute to that goal by enabling a controlled comparison between tagged and near-native recombinant proteins, especially when low-temperature processing helps preserve fragile assemblies. The next practical step is not to claim that tag removal explains the in vivo phenotype, but to use cleavage, mock cleavage, and orthogonal interaction measurements to test which biochemical properties are intrinsic to dKeap1 or lamin Dm0. In that role, PreScission Protease is a precise workflow component that improves experimental interpretability without replacing biological validation.